|
|
|
Abnormal electrolyte levels in people with eating disorders may increase risk of death, poor health outcomes
September 17,
2024
-
A new study found that 32% of individuals with an eating disorder had abnormal electrolyte levels, which were associated with a higher risk of death from any cause.
|
|
|
|
|
|
$2.8M grant to support Canada-wide trial of cell therapy for preterm babies
September 16,
2024
-
“This trial could change the way we care for premature babies. It’s my hope that these tiny patients will have a better chance to thrive, grow up, and have an impact on the world around them."
|
|
|
|
|
|
Clinical trial to test muscular dystrophy therapy developed at The Ottawa Hospital
September 10,
2024
-
Researchers at The Ottawa Hospital, the University of Ottawa and Satellos Bioscience have developed an innovative regenerative therapy for Duchenne muscular dystrophy (DMD) that is now being tested in people as part of a world-first clinical trial.
|
|
|
|
|
|
Dr. John Bell awarded Lifetime Contribution Prize from the Canadian Cancer Society
September 4,
2024
-
Dr. John Bell has been awarded the Lifetime Contribution Prize from the Canadian Cancer Society in recognition of his international leadership in cancer biotherapeutics, including the discovery and development of cancer-killing viruses and ...
|
|
|
|
|
|
Lab study provides new hope for people with rare muscle disease
August 29,
2024
-
Researchers from The Ottawa Hospital and uOttawa played a key role in a study that could lead to a new understanding of facioscapulohumeral muscular dystrophy (FSHD).
|
|
|
|
See all news items | See only press releases | Search for news and experts by disease / specialty
|
|
|
Media contacts
Amelia Buchanan
Senior Communication Specialist
613-297-8315
ambuchanan@ohri.ca
Jennifer Ganton
Director, Communications and Public Relations,
613-614-5253
jganton@ohri.ca
|
